Insider Transactions Reported by 25 Insiders of Sana Biotechnology, Inc.

Symbol
SANA on Nasdaq
Location
Seattle, WA

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Sana Biotechnology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Flagship Ventures Fund V General Partner LLC 10%+ Owner $133,203,349 06 Jun 2023
Flagship Pioneering, LLC 10%+ Owner $117,367,186 12 Feb 2024
KEITH CRANDELL 10%+ Owner $68,453,121 08 Feb 2024
ARCH Venture Fund X, L.P. 10%+ Owner $68,453,121 08 Feb 2024
Steve Harr President & CEO, Director $34,345,246 06 Mar 2026
Hans Edgar Bishop Director $24,124,008 05 Jan 2026
Richard Mulligan Director $10,489,755 05 Jun 2025
FMR LLC Other*, 10%+ Owner $7,493,594 08 Jan 2025
Christian Hordo EVP, Chief Business Officer $3,677,198 07 Mar 2024
James J. MacDonald EVP & General Counsel $3,021,815 13 Jun 2022
Susan D. Wyrick SVP, Finance and Accounting and Principal Accounting Officer $768,542 06 Mar 2026
Bernard J. Cassidy EVP & General Counsel $374,057 06 Mar 2025
Nathan Hardy EVP, Chief Financial Officer $368,957 07 Mar 2024
DOUGLAS E. WILLIAMS EVP & President, R&D $368,957 07 Mar 2024
SUNIL AGARWAL EVP, Head of Development & CMO 03 Mar 2022
Flagship Pioneering Fund VII General Partner LLC 10%+ Owner 12 Feb 2024
Mary Agnes Wilderotter Director 05 Jun 2025
Patrick Y. Yang Director 05 Jun 2025
Brian Piper EVP, Chief Financial Officer 17 Feb 2026
Robert L. Rosiello Director 05 Jun 2025
Douglas G. Cole Director 06 Jun 2024
ROBERT NELSEN Director, 10%+ Owner 05 Jun 2025
Joshua H. Bilenker Director 05 Jun 2025
Michelle Seitz Director 05 Jun 2025
ALISE REICIN Director 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for Sana Biotechnology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.